| 1 |
32377978 | Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low Cmax and improved tolerability, in patients with solid tumors. | 2020 Dec |
2 |
| 2 |
32774071 | Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. | 2020 Jul 21 |
1 |
| 3 |
31011915 | Pharmacokinetics of S-1 monotherapy in plasma and in tears for gastric cancer patients. | 2019 Jun |
2 |
| 4 |
31310349 | Histopathological changes in tumor budding between biopsy and resected specimens from patients treated with preoperative S-1 chemotherapy for oral cancer. | 2019 Nov |
2 |
| 5 |
28554183 | A Pilot Trial of S-1 and Paclitaxel in Unresectable or Postoperative Recurrent Esophageal Squamous Cell Carcinoma Pretreated by Fluorouracil, Cisplatin, and Docetaxel Chemotherapy. | 2018 |
3 |
| 6 |
29362333 | [Chemoradiotherapy with S-1 for Recurrence Cases of Colorectal Cancer]. | 2018 Jan |
1 |
| 7 |
29931401 | Determination of 5-fluorouracil and tegafur in tear fluid of patients treated with oral fluoropyrimidine anticancer agent, S-1. | 2018 Jul |
4 |
| 8 |
29945701 | [Efficacy of S-1 in Advanced Non-small Cell Lung Cancer Patients Treated
with More Than Two Lines of Chemotherapy]. | 2018 Jun 20 |
1 |
| 9 |
26715117 | Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer. | 2017 Jan |
1 |
| 10 |
27643822 | New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin. | 2017 |
3 |
| 11 |
28159957 | Pharmacokinetics of initial full and subsequent reduced doses of S-1 in patients with locally advanced head and neck cancer-effect of renal insufficiency. | 2017 May 1 |
3 |
| 12 |
28497756 | S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial. | 2017 Jun |
1 |
| 13 |
29045553 | Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer). | 2017 Nov 1 |
1 |
| 14 |
29137320 | A phase II study of S-1 with concurrent radiotherapy in elderly patients with esophageal cancer. | 2017 Oct 10 |
1 |
| 15 |
26811188 | S-1-based regimens and the risk of leucopenic complications; a Meta-analysis with comparison to other fluoropyrimidines and non fluoropyrimidines. | 2016 |
1 |
| 16 |
27076940 | A phase I dose escalation study of S-1 with concurrent radiotherapy in elderly patients with esophageal cancer. | 2016 Mar |
1 |
| 17 |
29874335 | S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil [Retraction]. | 2016 |
1 |
| 18 |
25423960 | HPV Status Determines the Efficacy of Adjuvant Chemotherapy With S-1, an Oral Fluorouracil Prodrug, in Oropharyngeal Cancer. | 2015 May |
2 |
| 19 |
25707610 | Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS). | 2015 Jun |
1 |
| 20 |
25756340 | Corneal limbal stem cell deficiency associated with the anticancer drug S-1. | 2015 Apr |
1 |
| 21 |
25810324 | Postgastrectomy pharmacokinetic changes of S-1 in patients with localized advanced gastric cancer. | 2015 Aug |
1 |
| 22 |
25932284 | Phase II multi-center clinical study on using S-1 to treat advanced breast cancer after resistance to anthracycline and taxane drugs in Chinese patients. | 2015 |
1 |
| 23 |
26025485 | Phase I study of postoperative radiotherapy concurrent with S-1 in patients with gastric cancer. | 2015 Jul |
1 |
| 24 |
26220845 | S-1 and irinotecan with or without bevacizumab versus 5-fluorouracil and leucovorin plus oxaliplatin with or without bevacizumab in metastatic colorectal cancer: a pooled analysis of four phase II studies. | 2015 Sep |
2 |
| 25 |
26811591 | Emerging role of S-1 in gastric cancer. | 2015 Oct-Dec |
1 |
| 26 |
25031751 | S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil. | 2014 |
3 |
| 27 |
25120809 | S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil. | 2014 |
3 |
| 28 |
25140293 | Synergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell lines. | 2014 |
1 |
| 29 |
25386059 | S-1 in the treatment of pancreatic cancer. | 2014 Nov 7 |
4 |
| 30 |
23719766 | S-1 (Teysuno®): a review of its use in advanced gastric cancer in non-Asian populations. | 2013 Jun |
2 |
| 31 |
23761814 | High efficacy of combination chemotherapy with S-1 and low-dose docetaxel for the treatment of highly advanced gastric cancer with peritoneal dissemination: A case report. | 2013 May |
1 |
| 32 |
23963147 | S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis. | 2013 Sep 17 |
1 |
| 33 |
23982118 | Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer. | 2013 Nov |
1 |
| 34 |
24047774 | [Phase I study of sequential S-1 and cyclophosphamide therapy in patients with metastatic breast cancer]. | 2013 Sep |
1 |
| 35 |
24156021 | Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer. | 2013 Aug |
1 |
| 36 |
21351099 | Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancer. | 2012 Jan 15 |
2 |
| 37 |
22235991 | S-1 as a core anticancer fluoropyrimidine agent. | 2012 Mar |
2 |
| 38 |
22322240 | Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy. | 2012 May |
2 |
| 39 |
22353201 | Pharmacokinetic study of weekly (days 1-5) low-dose S-1 in patients with non-small-cell lung cancer. | 2012 May |
1 |
| 40 |
22424872 | A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates. | 2012 Nov |
1 |
| 41 |
22740861 | Sequential irinotecan hydrochloride/S-1 for S-1-resistant inoperable gastric cancer: A feasibility study. | 2012 Jan |
1 |
| 42 |
22960985 | Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer. | 2012 Dec |
2 |
| 43 |
23033004 | Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601). | 2012 Oct 23 |
1 |
| 44 |
23291139 | [A phase II prospective randomized controlled trial of weekly paclitaxel combined with S-1 or fluorouracil for advanced gastric carcinoma]. | 2012 Nov |
1 |
| 45 |
20451285 | A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancer. | 2011 Jan |
1 |
| 46 |
20714726 | A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan. | 2011 Jun |
1 |
| 47 |
21079960 | The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice. | 2011 Aug |
2 |
| 48 |
21143703 | Comparison of the pharmacokinetics and pharmacodynamics of S-1 between Caucasian and East Asian patients. | 2011 Feb |
2 |
| 49 |
21273614 | Successful S-1 monotherapy for chemorefractory thymic carcinoma. | 2011 Jan |
1 |
| 50 |
21326246 | Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity. | 2011 Feb 15 |
1 |